NOVARTIS AG-SPONSORED ADR (NVS) Stock Balance Sheet
USA - NYSE:NVS - US66987V1098 - ADR
126.455 USD
-0.11 (-0.09%)
| MRQ (2025-9-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash | null | 2.58B | 3.21B | 2.88B | 3.40B | |||
| Cash Equivalents | 9.56B | 8.87B | 10.19B | 4.64B | 9.01B | |||
| Cash Due From Banks | null | null | null | null | null | |||
| Investments | null | null | null | null | null | |||
| Net Loans | null | null | null | null | null | |||
| Insurance Receivables | null | null | null | null | null | |||
| Marketable Securities | 112.00M | 1.89B | 680.00M | 11.21B | 15.71B | |||
| Receivables | 8.98B | 9.54B | 9.38B | 9.89B | 9.62B | |||
| Inventories | 6.42B | 5.72B | 5.91B | 7.17B | 6.67B | |||
| Other Current Assets | 3.13B | 1.09B | 1.12B | 1.11B | 1.32B | |||
| Total Current Assets | 28.20B | 29.70B | 30.48B | 36.91B | 45.72B | |||
| Non-Current Assets | ||||||||
| PPE Net | 11.99B | 10.87B | 10.92B | 12.20B | 13.11B | |||
| Investments And Advances | 2.15B | 1.13B | 1.83B | 1.61B | 2.27B | |||
| Goodwill | 25.55B | 24.76B | 23.34B | 29.30B | 29.59B | |||
| Intangibles | 29.04B | 26.91B | 26.88B | 31.64B | 34.18B | |||
| Other Non-Current Assets | 10.36B | 7.86B | 5.51B | 4.85B | 5.95B | |||
| Total Non-Current Assets | 79.09B | 72.54B | 69.46B | 80.54B | 86.08B | |||
| TOTAL ASSETS | 107.29B | 102.25B | 99.94B | 117.45B | 131.79B | |||
| LIABILITIES | ||||||||
| Total Deposits | null | null | null | null | null | |||
| Current Liabilities | ||||||||
| Short Term Borrowings | null | null | null | null | null | |||
| Short Term Debt | 0 | 4.73B | 3.89B | 3.63B | 3.61B | |||
| Current Portion Of LT Debt. | 7.71B | 3.59B | 2.42B | 2.49B | 2.90B | |||
| Accrued Expenses | null | 5.24B | 5.15B | 5.33B | 5.10B | |||
| Accounts Payable | 4.55B | 4.57B | 4.93B | 5.15B | 5.55B | |||
| Other Current Liabilities | 19.73B | 10.56B | 10.00B | 12.05B | 13.05B | |||
| Total Current Liabilities | 32.00B | 28.69B | 26.39B | 28.66B | 30.21B | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 24.24B | 22.93B | 20.03B | 21.78B | 24.52B | |||
| Deferred Taxes/Income | 2.17B | 2.42B | 2.25B | 2.69B | 3.07B | |||
| Other Non-Current Liabilities | 4.13B | 4.08B | 4.52B | 4.91B | 6.17B | |||
| Total Non-Current Liabilities | 30.96B | 29.51B | 26.89B | 29.45B | 33.93B | |||
| TOTAL LIABILITIES | 62.96B | 58.20B | 53.28B | 58.11B | 64.14B | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | 43.61B | 46.56B | 49.65B | 63.54B | 70.99B | |||
| Additional Paid In Capital | null | null | null | null | null | |||
| Minority Interest | 422.00M | 80.00M | 83.00M | 81.00M | 167.00M | |||
| Common Shares | 766.00M | 793.00M | 825.00M | 890.00M | 901.00M | |||
| Treasury Stock | -44.00M | -53.00M | -41.00M | -92.00M | -48.00M | |||
| Other Shareholders' Equity | null | -3.08B | -3.61B | -4.80B | -4.19B | |||
| Shares Outstanding | 1.91B | 1.97B | 2.04B | 2.12B | 2.23B | |||
| Tangible Book Value per Share | -5.3461 | -3.8606 | -1.7382 | -0.7563 | 1.7352 | |||
| Total Shareholders' Equity | 44.33B | 44.05B | 46.67B | 59.34B | 67.66B | |||
| TOTAL LIABILITIES AND EQUITY | 107.29B | 102.25B | 99.94B | 117.45B | 131.79B | |||
| Statistics | ||||||||
| Debt/Equity | 0.55 | 0.63 | 0.51 | 0.43 | 0.42 | |||
| Current Ratio | 0.88 | 1.04 | 1.16 | 1.29 | 1.51 | |||
| Return On Assets (ROA) | 13.42% | 11.68% | 14.86% | 5.92% | 18.23% | |||
| Return On Equity (ROE) | 32.47% | 27.11% | 31.82% | 11.72% | 35.51% | |||
| Return On Invested Capital (ROIC) | 22.36% | 18.92% | 14.81% | 10.02% | 9.46% | |||
| Return On Invested Capital Ex Cash (ROICexc) | 25.65% | 21.93% | 17.23% | 12.09% | 12.36% | |||
| Return On Invested Capital Ex Cash + Goodwill (ROICexgc) | 152.58% | 93.44% | 70.11% | 59.22% | 59.57% | |||
All data in USD , ROIC based on taxRate of 0.09